SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 43.51 |
Enterprise Value ($M) | 35.79 |
Book Value ($M) | 2.74 |
Book Value / Share | 0.08 |
Price / Book | 15.90 |
NCAV ($M) | 0.47 |
NCAV / Share | 0.01 |
Price / NCAV | 93.36 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -4.14 |
Return on Assets (ROA) | -1.50 |
Return on Equity (ROE) | -14.19 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.23 |
Current Ratio | 1.23 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 8.20 |
Assets | 10.47 |
Liabilities | 7.73 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | O'heeron Pete | |||
13G/A | BlackRock, Inc. |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
79,182 | 265,085 | 29.87 | |
39,754 | 154,086 | 25.80 | |
50,088 | 193,933 | 25.83 | |
100,826 | 271,694 | 37.11 | |
(click for more detail) |
Similar Companies | |
---|---|
ETNB – 89bio, Inc. | ETON – Eton Pharmaceuticals, Inc. |
FATE – Fate Therapeutics, Inc. | FHTX – Foghorn Therapeutics Inc. |
FOLD – Amicus Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io